City

Kurashiki (1)

Kyoto (1)

Nagoya (1)

Sakai (1)

Suita (1)

Tokushima (1)

Tokyo (1)

Tsu (1)

Condition

Familial Alzheimer Disease (FAD) (1)

PSEN1 Mutation (1)

Overall Status

Completed (1)

Phase

phase 1/phase 2 (1)

Sponsor

Kyoto University (1)

Collaborator

Asakayama Hospital (1)

Kawasaki Medical School Hospital (1)

Mie University (1)

Nagoya City University Hospital (1)

Osaka University (1)

Time Therapeutics, Inc. (1)

Tokushima University (1)

Tokyo Metropolitan Geriatric Medical Center (1)

Towa Pharmaceutical Co.,Ltd. (1)

Intervention

bromocriptine (1)

placebos (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

psen1 mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Familial Alzheimer (FAD), PSEN1 Mutation Trial in Japan (Bromocriptine, Placebos)

Completed

Familial Alzheimer Disease (FAD)
PSEN1 Mutation

Bromocriptine
Placebos

Nagoya, Aichi, Japan
+7 more

Mar 29, 2022